Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 65 results:
Author [ Title(Asc)] Type Year
Filters: Author is Azoulay, L.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
K. Tascilar, Azoulay, L., Dell'Aniello, S., Bartels, D. B., and Suissa, S., The Use of Telmisartan and the Incidence of Cancer, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study, Bmj, vol. 344, p. e3645, 2012.
B. B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and the incidence of lung cancer in patients with type 2 diabetes, Diabetes Care, vol. 36, pp. 124-9, 2013.
B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus, Cancer Epidemiol Biomarkers Prev, vol. 22, pp. 1877-83, 2013.
M. Tuccori, Wu, J. W., Yin, H., Majdan, A., and Azoulay, L., The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes, Diabetes Care, vol. 38, pp. 2083-9, 2015.
V. Mandilaras, Bouganim, N., Yin, H., Asselah, J., and Azoulay, L., The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer, Br J Cancer, vol. 116, pp. 103-108, 2017.
A. Douros, Abrahami, D., Yin, H., Yu, O. H. Y., Renoux, C., Hudson, M., and Azoulay, L., Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 904-912, 2018.
L. Azoulay, Soldera, S., Yin, H., and Bouganim, N., Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study, Epidemiology, vol. 27, pp. 594-601, 2016.
L. Azoulay, Yin, H., Renoux, C., and Suissa, S., The use of atypical antipsychotics and the risk of breast cancer, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
J. Assayag, Pollak, M. N., and Azoulay, L., The use of aspirin and the risk of mortality in patients with prostate cancer, J Urol, vol. 193, pp. 1220-5, 2015.
B. D. Fox, Azoulay, L., Dell'Aniello, S., Langleben, D., Lapi, F., Benisty, J., and Suissa, S., The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension, Can J Cardiol, vol. 30, pp. 1633-9, 2014.
F. Lapi, Azoulay, L., Kezouh, A., Benisty, J., Matok, I., Mugelli, A., and Suissa, S., The use of antidepressants and the risk of chronic atrial fibrillation, J Clin Pharmacol, vol. 55, pp. 423-30, 2015.
I
L. Azoulay, Dell'Aniello, S., Simon, T. A., Renoux, C., and Suissa, S., Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes, Eur Heart J, vol. 35, pp. 1881-7, 2014.
O. H. Yu, Filion, K. B., Azoulay, L., Patenaude, V., Majdan, A., and Suissa, S., Incretin-based drugs and the risk of congestive heart failure, Diabetes Care, vol. 38, pp. 277-84, 2015.
D. Abrahami, Yin, H., Yu, O. H. Y., Pollak, M. N., and Azoulay, L., Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 246-253, 2018.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study, Bmj, vol. 363, p. k4880, 2018.
J. L. Faillie, Azoulay, L., Patenaude, V., Hillaire-Buys, D., and Suissa, S., Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study, Bmj, vol. 348, p. g2780, 2014.
I. Matok, Azoulay, L., Yin, H., and Suissa, S., Immortal time bias in observational studies of drug effects in pregnancy, Birth Defects Res A Clin Mol Teratol, vol. 100, pp. 658-62, 2014.
C
L. Azoulay, Dell'Aniello, S., Huiart, L., Fort, G. G. du, and Suissa, S., Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
F. Lapi, Azoulay, L., Yin, H., Nessim, S. J., and Suissa, S., Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study, Bmj, vol. 346, p. e8525, 2013.
L. Azoulay, Dell'Aniello, S., Simon, T., Renoux, C., and Suissa, S., The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation, Thromb Haemost, vol. 109, pp. 431-9, 2013.
L. Azoulay, Schneider-Lindner, V., Dell'Aniello, S., Schiffrin, A., and Suissa, S., Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
O. H. Yu, Yin, H., and Azoulay, L., The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death, Can J Diabetes, vol. 39, pp. 383-9, 2015.
S. Y. Loo, Azoulay, L., Nie, R., Dell'Aniello, S., Yu, O. H. Y., and Renoux, C., Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study., Am J Med, 2019.
[Page last reviewed 4 October 2019]